305 related articles for article (PubMed ID: 15850970)
1. Maitake D-Fraction enhances antitumor effects and reduces immunosuppression by mitomycin-C in tumor-bearing mice.
Kodama N; Murata Y; Asakawa A; Inui A; Hayashi M; Sakai N; Nanba H
Nutrition; 2005 May; 21(5):624-9. PubMed ID: 15850970
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of cytotoxicity of NK cells by D-Fraction, a polysaccharide from Grifola frondosa.
Kodama N; Asakawa A; Inui A; Masuda Y; Nanba H
Oncol Rep; 2005 Mar; 13(3):497-502. PubMed ID: 15706424
[TBL] [Abstract][Full Text] [Related]
3. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
[TBL] [Abstract][Full Text] [Related]
4. Characterization and antitumor effect of a novel polysaccharide from Grifola frondosa.
Masuda Y; Matsumoto A; Toida T; Oikawa T; Ito K; Nanba H
J Agric Food Chem; 2009 Nov; 57(21):10143-9. PubMed ID: 19839588
[TBL] [Abstract][Full Text] [Related]
5. Maitake beta-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice.
Masuda Y; Inoue M; Miyata A; Mizuno S; Nanba H
Int Immunopharmacol; 2009 May; 9(5):620-6. PubMed ID: 19249389
[TBL] [Abstract][Full Text] [Related]
6. A polysaccharide extracted from Grifola frondosa enhances the anti-tumor activity of bone marrow-derived dendritic cell-based immunotherapy against murine colon cancer.
Masuda Y; Ito K; Konishi M; Nanba H
Cancer Immunol Immunother; 2010 Oct; 59(10):1531-41. PubMed ID: 20563803
[TBL] [Abstract][Full Text] [Related]
7. Administration of a polysaccharide from Grifola frondosa stimulates immune function of normal mice.
Kodama N; Murata Y; Nanba H
J Med Food; 2004; 7(2):141-5. PubMed ID: 15298759
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells coinjected with tumor cells treated with an anticancer drug to induce tumor rejection.
Inoue N; Yamasaki S; Kondo K; Kan T; Furumoto K; Imamura M
Surg Today; 2003; 33(4):269-76. PubMed ID: 12707821
[TBL] [Abstract][Full Text] [Related]
9. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antitumor effects of paclitaxel (taxol) in combination with red ginseng acidic polysaccharide (RGAP).
Shin HJ; Kim YS; Kwak YS; Song YB; Kim YS; Park JD
Planta Med; 2004 Nov; 70(11):1033-8. PubMed ID: 15549658
[TBL] [Abstract][Full Text] [Related]
11. [Effects of IgG-Fc-mitomycin C conjugate on cancer cells].
Baba E
Hokkaido Igaku Zasshi; 1996 Mar; 71(2):271-81. PubMed ID: 8641681
[TBL] [Abstract][Full Text] [Related]
12. [Synergistic antitumor effect of sodium caffeate and mitomycin].
Xu F; Song DQ; Zhen YS
Yao Xue Xue Bao; 2002 Jun; 37(6):405-8. PubMed ID: 12579792
[TBL] [Abstract][Full Text] [Related]
13. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
14. [Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy].
Shi M; Yao L; Wang FS; Lei ZY; Zhang B; Li WL; Liu JC; Tang ZR; Zhou GD
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):465-8. PubMed ID: 15555334
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific synergistic therapy of mitomycin C: modulation of bioreductive activation.
Sakamoto N; Toge T; Nishiyama M
Hiroshima J Med Sci; 1997 Jun; 46(2):67-73. PubMed ID: 9232934
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
[TBL] [Abstract][Full Text] [Related]
17. Preparation of a chemically sulfated polysaccharide derived from Grifola frondosa and its potential biological activities.
Nie X; Shi B; Ding Y; Tao W
Int J Biol Macromol; 2006 Nov; 39(4-5):228-33. PubMed ID: 16822541
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.
Braunschweiger PG; Jones SA; Johnson CS; Furmanski P
Cancer Res; 1991 Oct; 51(20):5454-60. PubMed ID: 1913664
[TBL] [Abstract][Full Text] [Related]
19. Potential antitumor activity of a low-molecular-weight protein fraction from Grifola frondosa through enhancement of cytokine production.
Kodama N; Mizuno S; Nanba H; Saito N
J Med Food; 2010 Feb; 13(1):20-30. PubMed ID: 20136432
[TBL] [Abstract][Full Text] [Related]
20. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
Ogura T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
